{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:25:44Z","timestamp":1782368744959,"version":"3.54.5"},"reference-count":86,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Plast Surg"],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Ever since the classification of Dupuytren disease into the proliferative, involutional, and residual stages, extensive research has been performed to uncover the molecular underpinnings of the disease and develop better treatment modalities for patients. The aim of this article is to systematically review the basic science literature pertaining to Dupuytren disease and suggest a new approach to treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Following Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines, a systematic review was conducted using the MEDLINE database to identify basic science literature on Dupuytren pathophysiology falling under 1 or more of the following categories: (1) Molecular alterations, (2) Structural alterations, and (3) Genetic predisposition.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 177 articles were reviewed of which 77 studies met inclusion criteria. Articles were categorized into respective sections outlined in the study methods.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The pathophysiological changes involved in Dupuytren\u2019s disease can be divided into a number of molecular and structural alterations with genetic predisposition playing a contributory role. Understanding these changes can allow for the development of biologics which may disrupt and halt the disease process.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sap.0000000000001918","type":"journal-article","created":{"date-parts":[[2019,6,22]],"date-time":"2019-06-22T17:12:48Z","timestamp":1561223568000},"page":"594-600","source":"Crossref","is-referenced-by-count":16,"title":["The Molecular Pathogenesis of Dupuytren Disease"],"prefix":"10.1097","volume":"83","author":[{"given":"Lohrasb R.","family":"Sayadi","sequence":"first","affiliation":[{"name":"Department of Plastic Surgery, Center for Tissue Engineering, University of California, Irvine, Orange"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danah","family":"Alhunayan","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Center for Tissue Engineering, University of California, Irvine, Orange"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Sarantopoulos","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Center for Tissue Engineering, University of California, Irvine, Orange"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Center for Tissue Engineering, University of California, Irvine, Orange"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Condamoor","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Center for Tissue Engineering, University of California, Irvine, Orange"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamasb","family":"Sayadi","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine, Stanford, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek A.","family":"Banyard","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Center for Tissue Engineering, University of California, Irvine, Orange"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashkaun","family":"Shaterian","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Center for Tissue Engineering, University of California, Irvine, Orange"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Leis","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Center for Tissue Engineering, University of California, Irvine, Orange"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R. D.","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Center for Tissue Engineering, University of California, Irvine, Orange"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Widgerow","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Center for Tissue Engineering, University of California, Irvine, Orange"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,6,21]]},"reference":[{"key":"bib1-20230923","first-page":"272","article-title":"Description of Dupuytren disease by the Basel physician and anatomist Felix Plater in 1614","volume":"27","year":"1995","journal-title":"Handchir Mikrochir Plast Chir"},{"key":"bib2-20230923","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1159\/000341470","article-title":"Microarray analysis of Dupuytren's disease cells: the profibrogenic role of the TGF-\u03b2 inducible p38 MAPK pathway","volume":"30","year":"2012","journal-title":"Cell Physiol Biochem"},{"key":"bib3-20230923","first-page":"635","article-title":"Dupuytren's contracture; a new concept of the pathogenesis correlated with surgical management","volume":"41-A","year":"1959","journal-title":"J Bone Joint Surg Am"},{"key":"bib4-20230923","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11552-008-9160-9","article-title":"Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology","volume":"4","year":"2009","journal-title":"Hand (NY)"},{"key":"bib5-20230923","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jhsa.2009.08.005","article-title":"Myofibroblast distribution in Dupuytren's cords: correlation with digital contracture","volume":"34","year":"2009","journal-title":"J Hand Surg [Am]"},{"key":"bib6-20230923","first-page":"185","article-title":"Myofibroblasts and extracellular matrix glycoproteins in palmar fibromatosis","volume":"142","year":"1997","journal-title":"Gen Diagn Pathol"},{"key":"bib7-20230923","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0363-5023(86)80143-5","article-title":"The cytoskeleton and extracellular matrix of the Dupuytren's disease \u201cmyofibroblast\u201d: an immunofluorescence study of a nonmuscle cell type","volume":"11","year":"1986","journal-title":"J Hand Surg [Am]"},{"key":"bib8-20230923","first-page":"252","article-title":"Evidence for the nonmuscle nature of the \u201cmyofibroblast\u201d of granulation tissue and hypertropic scar. An immunofluorescence study","volume":"130","year":"1988","journal-title":"Am J Pathol"},{"key":"bib9-20230923","first-page":"661","article-title":"Basic fibroblast growth factor in Dupuytren's contracture","volume":"141","year":"1992","journal-title":"Am J Pathol"},{"key":"bib10-20230923","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0363-5023(94)90059-0","article-title":"Comparative effects of growth factors on fibroblasts of Dupuytren's tissue and normal palmar fascia","volume":"19","year":"1994","journal-title":"J Hand Surg [Am]"},{"key":"bib11-20230923","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13075-015-0661-y","article-title":"Laminin-rich blood vessels display activated growth factor signaling and act as the proliferation centers in Dupuytren's contracture","volume":"17","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"bib12-20230923","doi-asserted-by":"crossref","first-page":"e59056","DOI":"10.1371\/journal.pone.0059056","article-title":"Genome-wide analysis using exon arrays demonstrates an important role for expression of extra-cellular matrix, fibrotic control and tissue remodelling genes in Dupuytren's disease","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"bib13-20230923","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jcp.46.5.425","article-title":"Abnormal growth factor and cytokine expression in Dupuytren's contracture","volume":"46","year":"1993","journal-title":"J Clin Pathol"},{"key":"bib14-20230923","first-page":"55","article-title":"Fibrin\/fibrinogen and fibrinolytic activity of the palmar fascia in Dupuytren's contracture","volume":"11","year":"1986","journal-title":"J Hand Surg (Br)"},{"key":"bib15-20230923","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jhsa.2005.09.007","article-title":"Expression of a novel gene, MafB, in Dupuytren's disease","volume":"31","year":"2006","journal-title":"J Hand Surg [Am]"},{"key":"bib16-20230923","first-page":"367","article-title":"Dupuytren's contracture. Fine structure in relation to aetiology","volume":"71","year":"1989","journal-title":"J Bone Joint Surg"},{"key":"bib17-20230923","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0266-7681(91)90051-O","article-title":"An investigation into the role of inflammatory cells in Dupuytren's disease","volume":"16","year":"1991","journal-title":"J Hand Surg (Br)"},{"key":"bib18-20230923","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3109\/17453674.2013.814011","article-title":"Expression of VEGF, its receptors, and HIF-1\u03b1 in Dupuytren's disease","volume":"84","year":"2013","journal-title":"Acta Orthop"},{"key":"bib19-20230923","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/path.2483","article-title":"An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren's disease","volume":"217","year":"2009","journal-title":"J Pathol"},{"key":"bib20-20230923","first-page":"10","article-title":"Identification of differentially expressed genes in fibroblasts derived from patients with Dupuytren's contracture","volume":"1","year":"2008","journal-title":"BMC Med Genet"},{"key":"bib21-20230923","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/bmj.295.6610.1373","article-title":"Free radicals and Dupuytren's contracture","volume":"295","year":"1987","journal-title":"Br Med J"},{"key":"bib22-20230923","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jhsa.2013.08.122","article-title":"Response of Dupuytren fibroblasts to different oxygen environments","volume":"38","year":"2013","journal-title":"J Hand Surg [Am]"},{"key":"bib23-20230923","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1101029","article-title":"Wnt signaling and Dupuytren's disease","volume":"365","year":"2011","journal-title":"N Engl J Med"},{"key":"bib24-20230923","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.trsl.2015.09.006","article-title":"Wnt pathway in Dupuytren disease: connecting profibrotic signals","volume":"166","year":"2015","journal-title":"Transl Res"},{"key":"bib25-20230923","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jss.2007.06.022","article-title":"The expression of myoglobin and ROR2 protein in Dupuytren's disease","volume":"146","year":"2008","journal-title":"J Surg Res"},{"key":"bib26-20230923","doi-asserted-by":"crossref","first-page":"e0158101","DOI":"10.1371\/journal.pone.0158101","article-title":"Meta-analysis of genome-wide association studies and network analysis-based integration with gene expression data identify new suggestive loci and unravel a Wnt-centric network associated with Dupuytren's disease","volume":"11","year":"2016","journal-title":"PLoS One"},{"key":"bib27-20230923","first-page":"33","article-title":"Further evidence of the involvement of the Wnt signaling pathway in Dupuytren's disease","volume":"10","year":"2016","journal-title":"J Cell communsignal"},{"key":"bib28-20230923","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","year":"2003","journal-title":"Nature"},{"key":"bib29-20230923","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.mehy.2011.11.023","article-title":"Concurrent inhibition of TGF-\u03b2 and mitogen driven signaling cascades in Dupuytren's disease\u2014non-surgical treatment strategies from a signaling point of view","volume":"78","year":"2012","journal-title":"Med Hypotheses"},{"key":"bib30-20230923","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1755-1536-4-14","article-title":"Elevated transforming growth factor \u03b2 and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease fibroblasts","volume":"4","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"bib31-20230923","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0266-7681(03)00135-9","article-title":"The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1","volume":"28","year":"2003","journal-title":"J Hand Surg (Edinburgh, Scotland)"},{"key":"bib32-20230923","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/J.JHSB.2006.05.007","article-title":"Feedback inhibition of high TGF-beta1 concentrations on myofibroblast induction and contraction by Dupuytren's fibroblasts","volume":"31","year":"2006","journal-title":"J Hand Surg (Br)"},{"key":"bib33-20230923","first-page":"E928","article-title":"Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target","volume":"110","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"bib34-20230923","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/BF02389692","article-title":"TGF beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin","volume":"27","year":"1995","journal-title":"Histochem J"},{"key":"bib35-20230923","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0363-5023(96)80102-X","article-title":"The role of transforming growth factor beta in Dupuytren's disease","volume":"21","year":"1996","journal-title":"J Hand Surg [Am]"},{"key":"bib36-20230923","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2474-12-113","article-title":"Reversal of TGF-\u03b21 stimulation of \u03b1-smooth muscle actin and extracellular matrix components by cyclic AMP in Dupuytren's-derived fibroblasts","volume":"12","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"bib37-20230923","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/03008207.2012.686542","article-title":"Expression of MMP-2, TIMP-2, TGF-\u03b21, and decorin in Dupuytren's contracture","volume":"53","year":"2012","journal-title":"Connect Tissue Res"},{"key":"bib38-20230923","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2474-5-41","article-title":"Enhanced Dupuytren's disease fibroblast populated collagen lattice contraction is independent of endogenous active TGF-beta2","volume":"5","year":"2004","journal-title":"BMC Musculoskelet Disord"},{"key":"bib39-20230923","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhsa.2004.02.008","article-title":"Expression of bone morphogenetic proteins by Dupuytren's fibroblasts","volume":"29","year":"2004","journal-title":"J Hand Surg [Am]"},{"key":"bib40-20230923","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/2000656X.2016.1140054","article-title":"Characterisation of the inflammatory response in Dupuytren's disease","volume":"50","year":"2016","journal-title":"J Plast Surg Hand Surg"},{"key":"bib41-20230923","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00694924","article-title":"Palmar fibromatosis (Dupuytren's contracture). Ultrastructural and enzyme histochemical studies of 43 cases","volume":"405","year":"1984","journal-title":"Virch Arch A"},{"key":"bib42-20230923","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"bib43-20230923","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1042\/CS20150088","article-title":"Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?","volume":"129","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"bib44-20230923","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/(SICI)1096-9896(199702)181:2<213::AID-PATH739>3.0.CO;2-4","article-title":"Myofibroblasts of palmar fibromatosis co-express transforming growth factor-alpha and epidermal growth factor receptor","volume":"181","year":"1997","journal-title":"J Pathol"},{"key":"bib45-20230923","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0363-5023(88)90261-4","article-title":"Prostaglandins influence myofibroblast contractility in Dupuytren's disease","volume":"13","year":"1988","journal-title":"J Hand Surg [Am]"},{"key":"bib46-20230923","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0363-5023(86)80093-4","article-title":"The pathobiology of Dupuytren's contracture: effects of prostaglandins on myofibroblasts","volume":"11","year":"1986","journal-title":"J Hand Surg [Am]"},{"key":"bib47-20230923","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jhsa.2006.12.011","article-title":"Immunohistochemical evidence of nerve growth factor in Dupuytren's diseased palmar fascia","volume":"32","year":"2007","journal-title":"J Hand Surg [Am]"},{"key":"bib48-20230923","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/J.JHSB.2005.06.008","article-title":"Epidermal growth factor receptor (EGF-R) in Dupuytren's disease","volume":"30","year":"2005","journal-title":"J Hand Surg (Br)"},{"key":"bib49-20230923","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.bbadis.2013.04.018","article-title":"IGF-II and IGFBP-6 regulate cellular contractility and proliferation in Dupuytren's disease","volume":"1832","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"bib50-20230923","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0736-0266(01)00072-9","article-title":"Androgen receptors in Dupuytren's contracture","volume":"20","year":"2002","journal-title":"J Orthop Res"},{"key":"bib51-20230923","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0363-5023(92)90414-K","article-title":"Platelet-derived growth factor in Dupuytren's disease","volume":"17","year":"1992","journal-title":"J Hand Surg [Am]"},{"key":"bib52-20230923","doi-asserted-by":"crossref","first-page":"e112457","DOI":"10.1371\/journal.pone.0112457","article-title":"Identification of histological patterns in clinically affected and unaffected palm regions in Dupuytren's disease","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"bib53-20230923","first-page":"59","article-title":"RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren's disease","volume":"8","year":"2015","journal-title":"BMC Med Genet"},{"key":"bib54-20230923","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2362.1980.tb00003.x","article-title":"Biochemistry and histology of the connective tissue of Dupuytren's disease lesions","volume":"10","year":"1980","journal-title":"Eur J Clin Investig"},{"key":"bib55-20230923","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.matbio.2004.06.001","article-title":"Increased formation of pyridinoline cross-links due to higher telopeptide lysyl hydroxylase levels is a general fibrotic phenomenon","volume":"23","year":"2004","journal-title":"Matrix Biol"},{"key":"bib56-20230923","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0363-5023(10)80136-4","article-title":"Transglutaminase levels in Dupuytren's disease","volume":"16","year":"1991","journal-title":"J Hand Surg [Am]"},{"key":"bib57-20230923","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.urology.2004.04.006","article-title":"Comparison of gene expression profiles between Peyronie's disease and Dupuytren's contracture","volume":"64","year":"2004","journal-title":"Urology"},{"key":"bib58-20230923","first-page":"68","article-title":"Inflammatory gene expression upon TGF-\u03b21-induced p38 activation in primary Dupuytren's disease fibroblasts","volume":"2","year":"2015","journal-title":"Front Mol Biosci"},{"key":"bib59-20230923","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jhsa.2007.11.010","article-title":"Molecular phenotypic descriptors of Dupuytren's disease defined using informatics analysis of the transcriptome","volume":"33","year":"2008","journal-title":"J Hand Surg [Am]"},{"key":"bib60-20230923","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.jhsa.2006.08.007","article-title":"Gelatinase a activity in Dupuytren's disease","volume":"31","year":"2006","journal-title":"J Hand Surg [Am]"},{"key":"bib61-20230923","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.bbadis.2012.02.001","article-title":"MMP-14 and MMP-2 are key metalloproteases in Dupuytren's disease fibroblast-mediated contraction","volume":"1822","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"bib62-20230923","first-page":"203","article-title":"Immunohistochemical expression and distribution of alpha2beta1, alpha6beta1, alpha5beta1 integrins and their extracellular ligands, type IV collagen, laminin and fibronectin in palmar fibromatosis","volume":"143","year":"1997","journal-title":"Gen Diagn Pathol"},{"key":"bib63-20230923","first-page":"55","article-title":"Appearance of the myofibroblastic phenotype in Dupuytren's disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix","volume":"62","year":"1994","journal-title":"J Immunopathol, Mol Cell Biol"},{"key":"bib64-20230923","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.2106\/00004623-198769090-00013","article-title":"Extracellular matrix-cytoskeletal connections at the surface of the specialized contractile fibroblast (myofibroblast) in Dupuytren disease","volume":"69","year":"1987","journal-title":"J Bone Joint Surg Am"},{"key":"bib65-20230923","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0040-8166(94)90057-4","article-title":"Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts","volume":"26","year":"1994","journal-title":"Tissue Cell"},{"key":"bib66-20230923","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/path.1427","article-title":"The myofibroblast in wound healing and fibrocontractive diseases","volume":"200","year":"2003","journal-title":"J Pathol"},{"key":"bib67-20230923","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0344-0338(11)80655-2","article-title":"Differential expression of fibronectin splice variants, oncofetal glycosylated fibronectin and laminin isoforms in nodular palmar fibromatosis","volume":"191","year":"1995","journal-title":"Pathol Res Pract"},{"key":"bib68-20230923","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11552-010-9314-4","article-title":"Calcium-dependent signaling in Dupuytren's disease","volume":"6","year":"2011","journal-title":"Hand (New York, NY)"},{"key":"bib69-20230923","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jhsa.2010.07.009","article-title":"Dupuytren's fibroblast contractility by sphingosine-1-phosphate is mediated through non-muscle myosin II","volume":"35","year":"2010","journal-title":"J Hand Surg [Am]"},{"key":"bib70-20230923","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0266-7681(93)90125-Y","article-title":"A clinical, ultrastructural and immunochemical study of Dupuytren's disease","volume":"18","year":"1993","journal-title":"J Hand Surg (Br)"},{"key":"bib71-20230923","first-page":"727","article-title":"Intracellular actin as a marker for myofibroblasts in vitro","volume":"67","year":"1992","journal-title":"J Techn Methods Pathol"},{"key":"bib72-20230923","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1038\/jid.2013.219","article-title":"Isometric contraction of Dupuytren's myofibroblasts is inhibited by blocking intercellular junctions","volume":"133","year":"2013","journal-title":"J Invest Dermatol"},{"key":"bib73-20230923","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jdermsci.2016.04.015","article-title":"Dupuytren's disease susceptibility gene, EPDR1, is involved in myofibroblast contractility","volume":"83","year":"2016","journal-title":"J Dermatol Sci"},{"key":"bib74-20230923","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/17453674.2013.871138","article-title":"Expression of gap junction proteins connexins 26, 30, and 43 in Dupuytren's disease","volume":"85","year":"2014","journal-title":"Acta Orthop"},{"key":"bib75-20230923","first-page":"15","article-title":"Fibroblasts from phenotypically normal palmar fascia exhibit molecular profiles highly similar to fibroblasts from active disease in Dupuytren's contracture","volume":"5","year":"2012","journal-title":"BMC Med Genet"},{"key":"bib76-20230923","first-page":"1282","article-title":"Chromosome abnormalities in Dupuytren's disease","volume":"2","year":"1975","journal-title":"Lancet (London, England)"},{"key":"bib77-20230923","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0266-7681(92)90128-O","article-title":"Chromosomal abnormalities in Dupuytren's contracture and carpal tunnel syndrome","volume":"17","year":"1992","journal-title":"J Hand Surg (Br)"},{"key":"bib78-20230923","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/PRS.0b013e3182442343","article-title":"DNA copy number variations at chromosome 7p14.1 and chromosome 14q11.2 are associated with Dupuytren's disease: potential role for MMP and Wnt signaling pathway","volume":"129","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"bib79-20230923","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2106\/00004623-197658030-00016","article-title":"Treatment of Dupuytren's contracture. Long-term results after fasciotomy and fascial excision","volume":"58","year":"1976","journal-title":"J Bone Joint Surg Am"},{"key":"bib80-20230923","first-page":"e15","article-title":"Surgical complications associated with fasciectomy for Dupuytren's disease: a 20-year review of the English literature","volume":"10","year":"2010","journal-title":"Eplasty"},{"key":"bib81-20230923","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1097\/PRS.0b013e3182a4c3a9","article-title":"Percutaneous aponeurotomy and lipofilling: a regenerative alternative to flap reconstruction?","volume":"132","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"bib82-20230923","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/PRS.0b013e3182a3bf2b","article-title":"Adipose-derived stem cells inhibit the contractile myofibroblast in Dupuytren's disease","volume":"132","year":"2013","journal-title":"Plast Reconstr Surg"},{"key":"bib83-20230923","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1126\/science.aai8792","article-title":"Regeneration of fat cells from myofibroblasts during wound healing","volume":"355","year":"2017","journal-title":"Science (New York, NY)"},{"key":"bib84-20230923","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbrc.2008.08.014","article-title":"The content of bone morphogenetic proteins in platelets varies greatly between different platelet donors","volume":"375","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"bib85-20230923","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/17453670710015364","article-title":"Acidic preparations of platelet concentrates release bone morphogenetic protein-2","volume":"79","year":"2008","journal-title":"Acta Orthop"},{"key":"bib86-20230923","first-page":"7183734","article-title":"Allogeneic platelet releasate preparations derived via a novel rapid thrombin activation process promote rapid growth and increased BMP-2 and BMP-4 expression in human adipose-derived stem cells","volume":"2016","year":"2016","journal-title":"Stem Cells Int"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000001918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T01:05:27Z","timestamp":1695431127000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000001918"}},"subtitle":["Review of the Literature and Suggested New Approaches to Treatment"],"short-title":[],"issued":{"date-parts":[[2019,6,21]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0000000000001918","relation":{},"ISSN":["1536-3708","0148-7043"],"issn-type":[{"value":"1536-3708","type":"electronic"},{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6,21]]}}}